Multimedia - BioPharm International

ADVERTISEMENT

Multimedia

Extractables and Leachables Video

May 23, 2013

Editorial Director Rita Peters talks to with Ferdinand Dabu Director of Marketing at SGS live at Interphex

Big Pharma Leverages Early-Stage Risk with Innovative Options

April 2, 2013

In recent years, large pharmaceutical companies have launched a variety of initiatives to restock ailing pipelines and boost business performance including mergers and acquisitions, diversifying business portfolios to non-pharmaceutical products, downsizing, spinoffs, and entering the biopharmaceutical arena.

Opportunities and Challenges in Developing Stem Cell Therapies

April 2, 2013

A conversation with Armand Keating, the Epstein Chair in Cell Therapy and Transplantation at the University of Toronto prior to his presentation at Bio 2013

Special Considerations for Testing for Extractables and Leachables

May 30, 2013

Rita Peters, Editorial Director for Pharmaceutical Technology and BioPharm Inernational talks with Ferdinand Dabu, director of marketing at SGS live at Interphex 2013 about extractables and leachables. In this interview they discuss special considerations for testing for extractables and leachables for both small molecule and biological drug development.

Open Innovation: Transforming the Model of Biopharmaceutical R&D

April 15, 2013

Don Frail, Vice President, AstraZeneca Innovative Medicines Group discusses the company's approach to innovation and the upcoming session at the BIO International Convention

Key Elements of an Effective Testing Program to Identify Extractables and Leachables

May 30, 2013

Rita Peters, Editorial Director for Pharmaceutical Technology and BioPharm Inernational talks with Ferdinand Dabu, director of marketing at SGS live at Interphex 2013 about extractables and leachables. In this interview they discuss the key elements of an effective testing program to identify extractables from materials and leachables in drug products.

New Analytical Testing Procedures and Instruments for Extractables and Leachables

May 30, 2013

Rita Peters, Editorial Director for Pharmaceutical Technology and BioPharm Inernational talks with Ferdinand Dabu, director of marketing at SGS live at Interphex 2013 about extractables and leachables. In this interview they discuss new analytical testing procedures and instruments that are facilitating the testing processes or improving results.

Video: Risk Management of Adventitious Agent Contamination in Biopharmaceutical Products

February 29, 2012

During this podcast, we will discuss the causes and implications of Adventitious Agent Contamination for pharmaceutical and biopharmaceutical manufacturers. We will discuss ways in which Lancaster Laboratories is helping manufacturers minimize the risk for this contamination to avoid production delays.

Podcast: Key Business Considerations for Growing BioPharm Product Pipeline

February 10, 2012

BioPharm International interviews Tarja Mottram, CEO of Action for Results, on the marriage of science and business to ensure sustainable growth. Posted Feb. 2012.

ADVERTISEMENT

ADVERTISEMENT

Click here